Innate Pharma S.A. - American Depositary Shares (IPHA)
1.9200
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 4th, 8:29 AM EDT
Detailed Quote
Previous Close | 1.920 |
---|---|
Open | - |
Bid | 1.890 |
Ask | 2.010 |
Day's Range | N/A - N/A |
52 Week Range | 1.290 - 3.511 |
Volume | 178 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 22,579 |
Chart
About Innate Pharma S.A. - American Depositary Shares (IPHA)
Innate Pharma S.A. is a biotechnology company focused on developing immunotherapy treatments for cancer. The company specializes in harnessing the body’s immune system to target and eliminate cancer cells. Innate Pharma is primarily engaged in the research and development of novel therapeutic antibodies and proprietary platforms that aim to enhance the immune response against tumors. Through its innovative programs, the company collaborates with other organizations to advance its promising candidates through clinical trials, with the ultimate goal of improving outcomes for cancer patients. Read More
News & Press Releases
Regulatory News:
By Innate Pharma SA · Via Business Wire · April 3, 2025
Regulatory News:
By Innate Pharma SA · Via Business Wire · March 27, 2025
Regulatory News:
By Innate Pharma SA · Via Business Wire · March 26, 2025
Regulatory News:
By Innate Pharma SA · Via Business Wire · March 25, 2025
Regulatory News:
By Innate Pharma SA · Via Business Wire · March 20, 2025

Regulatory News:
By Innate Pharma SA · Via Business Wire · February 27, 2025

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · February 18, 2025

Via Benzinga · February 18, 2025

Regulatory News:
By Innate Pharma SA · Via Business Wire · February 17, 2025

Via Benzinga · January 27, 2025

Regulatory News:
By Innate Pharma SA · Via Business Wire · January 27, 2025

Regulatory News:
By Innate Pharma SA · Via Business Wire · January 21, 2025

Regulatory News:
By Innate Pharma SA · Via Business Wire · January 16, 2025

Regulatory News:
By Innate Pharma SA · Via Business Wire · January 10, 2025

Regulatory News:
By Innate Pharma SA · Via Business Wire · December 20, 2024

Via Benzinga · December 16, 2024

Via Benzinga · December 16, 2024

Via Benzinga · December 9, 2024

Regulatory News:
By Innate Pharma SA · Via Business Wire · December 9, 2024

Via Benzinga · December 6, 2024

Regulatory News:
By Innate Pharma SA · Via Business Wire · December 6, 2024

Regulatory News:
By Innate Pharma SA · Via Business Wire · December 3, 2024

Regulatory News:
By Innate Pharma SA · Via Business Wire · November 20, 2024

Regulatory News:
By Innate Pharma SA · Via Business Wire · November 19, 2024